Influenza Update: Hospital Admissions Double During post-Thanksgiving Week

News
Article

Infographic

Centers for Disease Control and Prevention director Rochelle Walensky on Monday said during a telebriefing that new admissions to the nation's hospitals doubled in the week following Thanksgiving with the increase most notable among adults aged ≥70 years.

In another sign that the 2022-2023 influenza season is off to a sobering start GoodRx reports that prescription fills for the antiviral medication Tamiflu and oseltamivir, its generic, are up by 100% over this time last year.

Scan the data snapshot here of Flu in the USA, based on the latest CDC Weekly US influenza surveillance report and other official sources.

a Johns Hopkins Weekly Hospital Trends
b IPSOS/NORC Cumulative Influenza Vaccination Coverage and Intent for Vaccination
c GoodRx Flu Season Tracking Tamiflu Fills

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
New Study Suggests Bacterial Vaginosis May be Sexually Transmitted

New Study Suggests Bacterial Vaginosis May be Sexually Transmitted

Sydney Jennings
March 28th 2025
Article

New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

UK Research Collaborative Will Evaluate GSK Shingles Vaccine Effect on Dementia

UK Research Collaborative Will Evaluate GSK Shingles Vaccine Effect on Dementia

Grace Halsey
March 26th 2025
Article

GSK is partnering with the UK Dementia Research Institute and Health Data Research UK to further investigate the potential for the RZV vaccine to mitigate cognitive decline.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Long COVID's Long Road: A Year-5 Update with Noah Greenspan DPT, PT, CCS, EMT-B

Long COVID's Long Road: A Year 5 Update with Noah Greenspan DPT, PT, CCS, EMT-B

Infection Control Today® Editorial Staff
March 26th 2025
Article

Five years after the COVID-19 pandemic was declared, the protean syndrome dubbed long COVID continues to affect millions; Greenspan is dedicated to helping.

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs

Sydney Jennings
March 25th 2025
Article

Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.

© 2025 MJH Life Sciences

All rights reserved.